FDA Approved: RHOPRESSA — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approves a supplemental application for RHOPRESSA (netarsudil) filed by Alcon Laboratories, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• RHOPRESSA (NETARSUDIL)

Snippet

SUPPL AP for RHOPRESSA (NETARSUDIL)